Symptoms Experienced by Mesothelioma Patients: Use of the Lung Cancer Symptom Scale to Assess Impact on Quality of Life in Patients With Malignant Pleural Mesothelioma

2.50
Hdl Handle:
http://hdl.handle.net/10755/165425
Category:
Abstract
Type:
Presentation
Title:
Symptoms Experienced by Mesothelioma Patients: Use of the Lung Cancer Symptom Scale to Assess Impact on Quality of Life in Patients With Malignant Pleural Mesothelioma
Author(s):
Paolilli, D.; Tyson, L.; Krug, L.
Author Details:
D. Paolilli, Memorial Sloan-Kettering Cancer Center, New York, New York, USA; L. Tyson; L. Krug
Abstract:
Although much research has focused on understanding the symptoms of lung cancer, there has been little attention focused on understanding the symptoms of patients with malignant pleural mesothelioma (MPM). MPM is a rare, aggressive tumor that is associated with exposure to asbestos and SV40 virus. The incidence is rising steadily with 2,000-3,000 new cases diagnosed annually in the United States. Initial symptoms at presentation include dyspnea, cough and chest pain, fatigue, weight loss and fever. The thoracic oncology service at this NCI designated comprehensive cancer center sought an objective measure of presentation symptoms in this patient population. It was perceived that patients with MPM present with greater frequency and severity of symptoms than those patients with other thoracic malignancies. The Lung Cancer Symptom Scale (LCSS) was identified as a possible tool for measuring disease specific symptoms of MPM. The LCSS is a disease specific instrument that measures the physical and functional dimensions of quality of life (Hollen 1993). It has been found to be feasible, reliable, and valid in patients with non-small and small cell lung cancers and thought to be reasonable for use in this population of patients. As part of a phase II trial testing a new chemotherapy agent in patients with MPM, patients are given the LCSS prior to treatment with any chemotherapy and then monthly while on treatment. To date, 10 patients have been entered on the trial with a total accrual goal of 37 patients. This abstract will present an overview of MPM, our experience using the LCSS, and report the frequency and severity of symptoms seen in patients with MPM. As we present the symptom profile of MPM patients we will describe the role of the oncology nurse providing symptom-focused interventions in a nursing care plan format.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2003
Conference Name:
28th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Denver, Colorado, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleSymptoms Experienced by Mesothelioma Patients: Use of the Lung Cancer Symptom Scale to Assess Impact on Quality of Life in Patients With Malignant Pleural Mesotheliomaen_GB
dc.contributor.authorPaolilli, D.en_US
dc.contributor.authorTyson, L.en_US
dc.contributor.authorKrug, L.en_US
dc.author.detailsD. Paolilli, Memorial Sloan-Kettering Cancer Center, New York, New York, USA; L. Tyson; L. Krugen_US
dc.identifier.urihttp://hdl.handle.net/10755/165425-
dc.description.abstractAlthough much research has focused on understanding the symptoms of lung cancer, there has been little attention focused on understanding the symptoms of patients with malignant pleural mesothelioma (MPM). MPM is a rare, aggressive tumor that is associated with exposure to asbestos and SV40 virus. The incidence is rising steadily with 2,000-3,000 new cases diagnosed annually in the United States. Initial symptoms at presentation include dyspnea, cough and chest pain, fatigue, weight loss and fever. The thoracic oncology service at this NCI designated comprehensive cancer center sought an objective measure of presentation symptoms in this patient population. It was perceived that patients with MPM present with greater frequency and severity of symptoms than those patients with other thoracic malignancies. The Lung Cancer Symptom Scale (LCSS) was identified as a possible tool for measuring disease specific symptoms of MPM. The LCSS is a disease specific instrument that measures the physical and functional dimensions of quality of life (Hollen 1993). It has been found to be feasible, reliable, and valid in patients with non-small and small cell lung cancers and thought to be reasonable for use in this population of patients. As part of a phase II trial testing a new chemotherapy agent in patients with MPM, patients are given the LCSS prior to treatment with any chemotherapy and then monthly while on treatment. To date, 10 patients have been entered on the trial with a total accrual goal of 37 patients. This abstract will present an overview of MPM, our experience using the LCSS, and report the frequency and severity of symptoms seen in patients with MPM. As we present the symptom profile of MPM patients we will describe the role of the oncology nurse providing symptom-focused interventions in a nursing care plan format.en_GB
dc.date.available2011-10-27T12:18:19Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:18:19Z-
dc.conference.date2003en_US
dc.conference.name28th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationDenver, Colorado, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.